Autonomix secures patent for nerve-targeting medical device By Investing.com

THE WOODLANDS, TX – Autonomix Medical, Inc. (NASDAQ: AMIX), a medical device company specializing in nervous system diseases, announced the issuance of a new U.S. patent for its technology designed to treat cancer-related pain and augment organ function. The U.S. Patent and Trademark Office granted U.S. patent 10,143,419, which covers systems and methods including devices for treating…